Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INTC vs GSK✓SelectedUSD · GSKINTC vs GSK performance historyLatest closeAs of-7.97%11/20
Stock and ETF performance explorer

INTC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+16.2%
GSK return
+53.4%
Excess return
-37.2%
Maximum drawdown
-63.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.0%-0.1%-7.8%-8.0%
7D-14.0%-5.3%-8.7%-14.1%
30D-44.8%-3.7%-41.2%-44.8%
3M-44.3%-7.3%-37.1%-44.1%
6M-56.9%-4.2%-52.7%-57.0%
YTD+39.0%+0.9%+38.1%+37.0%
1Y+52.5%+7.3%+45.3%+48.6%
3Y+16.2%+52.7%-36.6%+13.6%
All+16.2%+53.4%-37.2%+13.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling